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Krüppel-like factor 6 (KLF6) is a transcription factor involved in the regulation of
several cellular processes. Regarding its role in tumorigenesis, KLF6 is considered
a tumor suppressor. Numerous reports demonstrate its frequent genomic loss or
down-regulation, implying a functional inactivation in a broad range of human cancers.
Previous work from our laboratory showed that the down-regulation of KLF6 expression
in normal fibroblasts leads to cellular transformation, while its ectopic expression
interferes with the oncogenic transformation triggered by activated Ras through a cell
cycle arrest. We hypothesize that the growth suppressor activity of KLF6 may involve the
induction of cellular senescence thereby helping to prevent the proliferation of cells at risk
of neoplastic transformation. Here, we explored the association of KLF6 up-regulation
in two different cellular senescence scenarios. We found that KLF6 silencing bypasses
both oxidative and oncogene-induced senescence. In this context, KLF6 expression per
se was capable to trigger cellular senescence in both normal and tumoral contexts. As
such, the findings presented in this report provide insights into a potential mechanism by
which KLF6 may play a suppressing role of uncontrolled or damaged cell proliferation.
Keywords: KLF6, cellular senescence, DNA damage, cell proliferation, ras oncogene
INTRODUCTION
Krüppel-like factor 6 (KLF6) belongs to a zinc-finger-containing transcription factors family
and has been implicated in the regulation of several cellular processes including development,
proliferation, inflammation, apoptosis, and differentiation (Bieker, 2001; Ito et al., 2004; Matsumoto
et al., 2006; DiFeo et al., 2009; McConnell and Yang, 2010; Racca et al., 2011; Racca et al., 2015).
KLF6 transcription factor has a growing list of target genes, many of which are involved in cell
cycle regulation (Tetreault et al., 2013). For example, KLF6 up-regulates cyclin-dependent kinase
(CDK) inhibitors such as p21WAF1/Cip1 (Narla et al., 2001; Narla et al., 2007) and interacts with
other transcription factors as Sp1, KLF4, and p53 (Rubinstein et al., 2004; DiFeo et al., 2009). KLF6
is reputed as tumor suppressor since numerous reports demonstrate its frequent genomic loss or
down-regulation, implying a functional inactivation, in a broad range of human cancers such as
glioblastoma, hepatocellular carcinoma, gastric carcinoma, colorectal, prostate, ovarian, breast, and
non-small-cell lung cancers (Narla et al., 2001; Kimmelman et al., 2004; Kremer-Tal et al., 2004;
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Narla et al., 2007; Bureau et al., 2009; DiFeo et al., 2009; Tetreault
et al., 2013). In addition, previous reports from our laboratory
showed that KLF6 down-regulation leads to spontaneous
transformation of NIH3T3 fibroblasts (Trucco et al., 2014).
Also, KLF6 ectopic expression impaired H-RasG12V-mediated
cell growth and transformed phenotype (Trucco et al., 2014).
Within the strategies to limit cell growth in cells with
uncontrolled proliferation, cellular senescence is now believed to
play a critical role in the suppression of tumorgenesis in various
organs (Campisi, 2001; Braig et al., 2005; Bartkova et al., 2006;
Prieur and Peeper, 2008; Vizioli et al., 2011; Sabatino et al., 2015).
Cellular senescence involves cell cycle arrest, resulting in a stable
loss of proliferative capacity. This can be elicited through various
genotoxic stimuli, including telomere dysfunction, oncogenes
activation, DNA damage and oxidative stress (Serrano et al., 1997;
Lee et al., 2006; Campisi and d’Adda di Fagagna, 2007; Mallette
et al., 2007). This cellular program is achieved primarily by the
activation of senescence-associated genes such as p53 and pRb
(Di Leonardo et al., 1994; Campisi, 2001), which are frequently
mutated in a large number of cancers (Burkhart and Sage, 2008;
Levine and Oren, 2009). The presumed role of KLF6 as tumor
suppressor comes from its ability to reduce cell proliferation
through different cellular mechanisms as the regulation of cell
cycle components, oncogene signaling and apoptosis (Ito et al.,
2004; Kimmelman et al., 2004; Narla et al., 2007). However,
it is currently unknown whether KLF6 participates in the
induction and/or maintenance of cellular senescence. Given
KLF6 ubiquitous expression and its capability to suppress cell
growth, we hypothesized that KLF6 may be involved in the
induction of cellular senescence mechanism, preventing the
proliferation of cells at risk of neoplastic transformation.
Results presented in this report revealed that KLF6 silencing
interfered with oxidative and oncogene-induced cellular
senescence in NIH3T3 fibroblasts. Additionally, ectopic KLF6
expression was able to induce cellular senescence in normal
and tumoral cells. These findings provide evidence for KLF6
involvement in the molecular basis underlying the induction and
maintenance of cellular senescence.
MATERIALS AND METHODS
Cell Culture
All cell lines were obtained from the American Type Culture
Collection (ATCC, Manassas, VA, United States). NIH3T3 and
HeLa cells were cultured in Dulbecco’s modified Eagle medium
(DMEM; Gibco, Carlsbad, CA, United States) supplemented with
10% newborn calf serum (Gibco) and penicillin/streptomycin
(P3032 and S9137, Sigma-Aldrich, St. Louis, MO, United States).
To trigger oxidative-induced cellular senescence, murine
NIH3T3 fibroblasts were treated with H2O2 (150 µM for
2 h in 0.5% newborn calf serum) and processed after 6 days
(cultured in 2.5% newborn calf serum) for detection of SA-β-Gal
senescence marker or DDR markers (p53, p21, γH2AX, and
pATM) or KLF6 expression. Cell lines stably transduced to
express a constitutively active form of Ras (H-RasG12V) or KLF6
under the control of a tetracycline-inducible promoter were
maintained in DMEM containing 10% Tet system approved
fetal bovine serum (#631106, Clontech, Mountain View, CA,
United States) and treated with tetracycline (0.1 µg/mL and
1.0 µg/mL, #87128, Sigma-Aldrich) during 6 days and processed
as described above for H2O2 treatment. NIH3T3 and HeLa
cells were mycoplasma-free as determined by both, Hoechst
staining and PCR.
Establishment of Stable Cells
Lentiviruses were generated as described in Trucco et al.
(2014) by cotransfecting HEK293T cells with pCMV-
dR8.2- vpr and pCMV-VSV-G helper plasmids and the
appropriate transfer expression vector (pLKO.1-SCR,
pLKO.1-shKLF6-A, pLKO.1-shKLF6-B, pLenti3.3/TR, pLenti-
CMV/TO/RasV12-Puro, pLenti6.3/TO/RasV12, pLenti6.3/-
TO/KLF6). The 21-mer target sequences were scrambled
(SCR), 5′-GTTAACTGCGTACCTTGAGTA; shKLF6-A, 5′-
ACAGGGAATCTTCTCAACTAT; and shKLF6-B, 5′-GATCC
CATTGGTGAAGTCTTA. Viral supernatants were collected
48 h after transfection, supplemented with 6 µg/ml polybrene
(sc-134220, Santa Cruz Biotechnology, Santa Cruz, CA,
United States), and used for transduction of NIH3T3 cells
(multiplicity of infection, 0.5). After 48 h, the cells were
resuspended in fresh medium containing puromycin (P-8833,
Sigma-Aldrich, St. Louis, MO, United States) or blasticidin
(R21001, Thermo Fisher Scientific, Waltham, MA, United States)
and selected during 3 weeks. Human cervix cancer HeLa cells
stably modify as previously described (D’Astolfo et al., 2008)
to express KLF6 under the control of a tetracycline-inducible
promoter were treated with 0.1 and 1.0 µg/mL of doxycycline
(D9891, Sigma-Aldrich) during 6 days and processed.
Western Blot Analysis
Western blot analysis was performed as previously described
(Racca et al., 2011) and the following antibodies were used:
rabbit polyclonal anti-H-Ras (C-20, sc-520, Santa Cruz), mouse
monoclonal anti-KLF6 [clone 2c11, previously specified by
Gehrau et al. (2011)], rabbit and goat polyclonal anti-p53 (sc6243,
Santa Cruz Biotechnology), mouse anti- α -tubulin (T9026,
Sigma-Aldrich), mouse anti-β-actin (A5316, Sigma-Aldrich)
and donkey-anti-mouse near-Infrared fluorescent secondary
antibodies 680CW and 800CW (LI-COR Biosciences, Lincoln,
NE, United States). α-tubulin and β-actin were used as loading
control. Fluorescence emission was acquired with Odyssey CLx
scan (LI-COR, United States). Images are representative of three
independent experiments.
Immunofluorescence Detection
Fluorescence immunodetection was carry on as previously
described (Sabatino et al., 2013) and the following antibodies
were used: rabbit or goat polyclonal anti-p53 (sc6243, Santa
Cruz Biotechnology), mouse monoclonal anti-phospho-Histone
γH2AX (Ser139) (#2577, Cell Signaling Technology, Beverly,
MA, United States), mouse monoclonal anti-p21Waf1/Cip1(2947S,
Cell Signaling Technology) and mouse monoclonal anti-ATM
(phospho S1981) antibody (ab36810, Abcam, Cambridge,
United Kingdom), Alexa Fluor 488 donkey anti-mouse or
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anti-rabbit (Jackson Immunoresearch, West Grove, PA,
United States). Nuclei area is represented by yellow contours
extracted from Hoechst fluorescence staining. Micrographs
were obtained with a Leica Microscope (Leica DMi8, Leica
Microsystems, Wetzlar, Germany) at X630 magnification
and are representative of three independent experiments.
Fluorescence intensity of each antibody fluorochrome emission
was evaluated in five random chosen fields and normalized by
total DNA content area.
SA-β-Gal Detection Assay
To detect senescence associated-β-galactosidase (SA-β-Gal)
staining (cytoplasmic blue stain) as previously described
(Debacq-Chainiaux et al., 2009) using X-Gal (X-Gal-RO, Sigma-
Aldrich). Nuclear fluorescent dye Hoechst was applied to denote
cell nuclei (gray stain). Images were captured with Fluoview
1000 (Olympus, Tokyo, Japan) at X400 magnification and
are representative of three independent experiments. Image
processing was performed with ImageJ software (National
Institutes of Health, Bethesda, MD, United States). Cellular
senescence index expressed as the percentage of SA-β-Gal
positive cells and was obtained counting a minimum of 500 cells
on randomly chosen fields from three independent experiments.
Statistical Analysis
Data are presented as media ± SEM. Unless otherwise reported,
one-way ANOVA was used for three independent samples with
normal distribution (Wilk–Shapiro test) and homoscedasticity
(Levene test). Where data did not meet the assumptions of
the test, Generalized Linear Mixed Model (GLMM) test was
used (Di Rienzo and Re Casanoves, 2017). Fisher Test was
applied to detect significant difference, p < 0.05 using InfoStat
software (Grupo InfoStat, Facultad de Ciencias Agropecuarias,
Universidad Nacional de Córdoba, Córdoba, Argentina).
RESULTS
KLF6 Expression Is Induced Upon
Oxidative and Oncogene-Induced
Cellular Senescence
Cellular senescence phenomenon is usually detected by the
elevation of senescence-associated β-galactosidase (SA–β-Gal)
enzyme activity (Dimri et al., 1995; Lee et al., 2006). Additionally,
senescent phenotypes usually correlate with the accumulation
of DNA damage markers such as γ-H2AX (histone γ-H2AX)
and pATM (phosphorylated Ataxia Telangiectasia Mutated)
(Di Micco et al., 2006), as well as the activation of p53 or Rb
pathways, coupled by the accumulation of CDK inhibitors
as p21 (Roninson, 2002; Holst et al., 2003). In this study,
we have evaluated KLF6 involvement in the senescence
process triggered by two different stimuli: i- an oncogenic
stress attained by the expression of a constitutively active
Ras form (H-RasG12V) under the control of a tetracycline
responsive promoter (0.1–1.0 µg/ml for 6 days) and ii-
oxidative treatment of cells with H2O2, as described previously
(Volonte et al., 2002). H-Ras expression was confirmed
by immunoblotting (Figure 1A). By SA-β-Gal activity
determination, a significant increase in the index of cellular
senescence was detected in murine fibroblasts NIH3T3 after
6 days either in response to H-RasG12V expression (46 ± 6
and 40 ± 6%, dose, respectively, p < 0.05, Figure 1B) or
H2O2 treatment (66 ± 7%, p < 0.05, Figure 2A). Tetracycline
treatment, per se, did not lead to significant changes in the
cellular senescence index nor increments in KLF6 protein
expression (Supplementary Figures 1A,B). Both senescence
phenotypes were accompanied by increments in p21 expression
levels and hallmarks of DNA damage response activation,
as highlighted by immunostaining of p21, γ-H2AX, pATM,
and p53 protein levels (Figures 1C, 2C). In addition, each
stimulus also increased the apoptosis rate, as assessed by
Annexin V/propidium iodide staining (p < 0.05, Supplementary
Figures 2B,D). The splice variants were not analyzed due to KLF6
splicing has not been described in mouse. Moreover, oxidative-
induced senescence correlated with a slower proliferation
rate (p < 0.05, Supplementary Figure 2A), while oncogenic
H-RasG12V expression shows an increase in the relative cell
number (p < 0.05, Supplementary Figure 2C), as it has been
previously reported (Trucco et al., 2014). Notably, both oncogene
and oxidative-induced cellular senescence processes were
accompanied by increased KLF6 protein expression (Figures
1A, 2B, respectively), showing different timepoints profile
(Supplementary Figures 1E–G), thus supporting a potential
association of KLF6 with cellular senescence modulation
in response to different triggers. Moreover, the H-RasG12V
oncogene stimulus showed an increase in KLF6 mRNA levels,
as previously reported (Trucco et al., 2014), although this effect
could not be detected for H2O2 treatment (Supplementary
Figures 1H–J).
KLF6 Silencing Impairs Oxidative and
Oncogene-Induced Cellular Senescence
To verify whether KLF6 is involved in cellular senescence
induction, we down-regulated endogenous KLF6 levels by stable
expression of a KLF6 shRNA in NIH3T3 fibroblasts (shKLF6).
Cells were then treated with H2O2 as described above, or
left untreated in fibroblasts that constitutively express the
active form of the H-RasG12V oncogene (ras/shKLF6). Two
different shKLF6 sequences were assayed and KLF6 down-
regulation was corroborated by immunoblotting (Figure 3B).
The shRNA sequence that led to more effective KLF6 silencing
was chosen for further experiments (Figures 3B, 4B). KLF6
down-regulation resulted in the attenuation of both oxidative
and oncogene stimuli ability to induce cellular senescence, as
was determined by a significant decrease in the rate of SA-
β-Gal positive cells (p < 0.05, Figures 3A, 4A). These findings
suggest that cellular senescence might be in part dependent
on KLF6 function.
Krüppel-like factor 6 silencing in both senescent contexts also
induced DNA damage markers, evaluated by immunodetection
of γ-H2AX, pATM, and p53 proteins (p < 0.05, Figures 3B,C,
4B,C), showed an increased number of apoptotic cells
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FIGURE 1 | Oncogene-induced senescence in NIH3T3 fibroblasts expressing H-RasG12V. (A) Immunoblotting from murine NIH3T3 fibroblasts expressing
H-RasG12V after 3 days of tetracycline treatment (0.1 and 1.0 µg/mL). Anti-α-tubulin was used as loading control. Images are representative of three independent
experiments. (B) Left: Representative micrograph of murine NIH3T3 fibroblasts stably transduced to express a constitutively active form of Ras (H-RasG12V) under
the control of a tetracycline-inducible promoter. Cells were treated with tetracycline (0.1 and 1.0 µg/mL) during 6 days and processed to detect senescence
associated-β-galactosidase (SA-β-Gal) staining (cytoplasmic blue stain). Nuclear fluorescent dye Hoechst was applied to denote cell nuclei (gray stain). Images were
captured at X400 magnification and are representative of three independent experiments. Right: Cellular senescence index expressed as the percentage of SA-β-Gal
positive cells in NIH3T3 fibroblast expressing H-RasG12V. (C) Representative micrograph of DNA damage response biomarkers: p53, p21, γ-H2AX, and phospho
ATM by fluorescence immunodetection on murine NIH3T3 fibroblasts expressing H-RasG12V under tetracycline control. Nuclei area is represented by yellow
contours extracted from Hoechst fluorescence staining at X630 magnification. Images are representative of three independent experiments. Fluorescence intensity of
each antibody fluorochrome emission was evaluated in five random chosen fields and normalized by total DNA content area. Data are presented as media ± SEM.
Fisher Test was applied to detect significant difference, p < 0.05.
accordingly to cell cytometer analysis (p < 0.05, Supplementary
Figures 2F,H) without modifications in the total cell number
(Supplementary Figures 2E,G). Moreover, it was observed that
decreased KLF6 expression, by itself, raised the basal cellular
senescence index (p < 0.05, Figure 3A), while increasing cell
proliferation rate (p < 0.05, Supplementary Figure 2E) and
γ-H2AX and p53 levels (p < 0.05, Figures 3B,C). Interestingly,
we also detected an elevated number of micronuclei, a hallmark
of genomic instability in KLF6-silenced fibroblasts (p < 0.05,
Supplementary Figures 2I,J). Taken together, these findings
suggest that KLF6 may contribute to DNA stability maintenance
as well as the modulation of apoptosis in the presence of oxidants
stressors and oncogenic stimuli.
Ectopic Expression of KLF6 Induces
Cellular Senescence in Normal and
Tumoral Contexts
To further explore KLF6 biological activity during the induction
of cellular senescence, we generated an NIH3T3 stable cell
line in which KLF6 expression is regulated by a tetracycline
responsive promoter (0.1–1.0 µg/ml for 6 days, Figure 3E).
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FIGURE 2 | Cellular senescence in NIH3T3 fibroblasts treated with H2O2. (A) Left: Representative micrograph of murine NIH3T3 fibroblasts treated with H2O2
(150 µM for 2 h) and processed after 6 days to detect SA-β-Gal staining (cytoplasmic blue stain). Nuclear fluorescent dye Hoechst was applied to denote cell nuclei
(gray stain). Images were captured at X400 magnification and are representative of three independent experiments. Right: Cellular senescence index expressed as
the percentage of SA-β-Gal positive cells. (B) KLF6 immunoblotting from murine NIH3T3 fibroblasts after 4 h of H2O2 treatment (150 µM for 2 h). Anti-α-tubulin was
used as loading control. Images are representative of three independent experiments. (C) Representative micrograph of DNA damage response biomarkers: p53,
p21, γ-H2AX and phospho ATM by fluorescence immunodetection on murine NIH3T3 fibroblasts treated with H2O2. Images are representative of three independent
experiments. Fluorescence intensity of each antibody fluorochrome emission was evaluated in five random chosen fields and normalized by total DNA content area.
Data are presented as media ± SEM. Fisher Test was applied to detect significant difference, p < 0.05.
The quantification of SA-β-Gal positive cells showed that the
ectopic expression of KLF6 was able to increase the cellular
senescence index (7.80 ± 1.08% p < 0.05, Figures 3D,F).
These data suggest that in normal contexts, without any specific
damage or stressful stimuli, KLF6 expression can trigger cellular
senescence. Also, to evaluate whether such KLF6 role can
be extended to tumoral contexts, we determined the rate of
cellular senescence in the cervical carcinoma HeLa cell line,
which was reported to express low levels of endogenous KLF6
protein (Gehrau et al., 2011). To this end we controlled KLF6
expression with doxycycline responsive promoter (0.1–1.0 µg/ml
for 6 days, Figure 3H). Doxycycline treatment, per se, did not
lead to significant changes in the HeLa cellular senescence index
nor increments in KLF6 protein expression (Supplementary
Figures 1C,D). Strikingly, increased expression of KLF6 in this
cell line was able to induce a significant increase in the proportion
of SA-β-Gal cells positive (7.86 ± 1.47 and 8.20 ± 1.47% doses,
respectively, p < 0.05, Figures 3G,I), suggesting that KLF6
tumor suppressor role could be related to the induction of the
cellular senescence.
DISCUSSION
An intricate interaction between diverse and divergent signaling
pathways governs the tumor cells ability to proliferate, survive,
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FIGURE 3 | Krüppel-like factor 6 silencing interferes with oxidative-induced cellular senescence. (A) Left: Representative micrograph of murine NIH3T3 fibroblasts
stably transduced to express either scramble (scr) or KLF6-specific shRNA (shKLF6) were treated with H2O2 (150 µM for 2 h) and processed after 6 days to detect
SA-β-Gal staining (cytoplasmic blue stain). Nuclear fluorescent dye Hoechst was applied to denote cell nuclei (gray stain). Images were captured at X400
magnification and are representative of three independent experiments. Right: Cellular senescence index expressed as the percentage of SA-β-Gal positive cells.
(B) KLF6 immunoblotting from murine NIH3T3 fibroblasts expressing scramble or KLF6-specific shRNA after 4 h of H2O2 treatment. Anti-α-tubulin was used as
loading control. Images are representative of three independent experiments. (C) Upper: Representative micrograph of DNA damage biomarker γ-H2AX in murine
fibroblast by fluorescence immunodetection. Nuclei area is represented by yellow contours extracted from Hoechst fluorescence staining. Images are representative
of three independent experiments. Lower: Fluorescence intensity of γ-H2AX antibody fluorochrome emission was evaluated in five random chosen fields and
normalized by total DNA content area. Two-way ANOVA was used to examine the effect of shKLF6 and H2O2 in three independent samples. (D) Representative
micrograph of murine NIH3T3 fibroblasts stably transduced to express KLF6 under the control of a tetracycline-inducible promoter were treated with tetracycline (0.1
and 1.0 µg/mL Sigma-Aldrich) during 6 days and processed to detect SA-β-Gal staining. Nuclear fluorescent dye Hoechst was applied to denote cell nuclei (gray
stain), X400 magnification. (E) KLF6 immunoblotting from murine NIH3T3 fibroblasts expressing KLF6 after tetracycline treatment. Anti-α-tubulin was used as loading
control. Images are representative of three independent experiments. (F) Cellular senescence index expressed as the percentage of SA-β-Gal positive cells in
NIH3T3 fibroblasts expressing KLF6. (G) Representative micrograph of human cervix cancer HeLa cells stably modify to express KLF6 under the control of a
doxycycline-inducible promoter were treated with 0.1 and 1.0 µg/mL of doxycycline (Sigma-Aldrich) during 6 days and processed to detect SA-β-Gal staining.
Nuclear fluorescent dye Hoechst was applied to denote cell nuclei (gray stain), X400 magnification. (H) KLF6 immunoblotting from HeLa cells expressing KLF6 after
doxycycline treatment. Mouse anti-β-actin (Sigma-Aldrich) was used as loading control. Images are representative of three independent experiments. (I) Cellular
senescence index expressed as the percentage of SA-β-Gal positive cells in HeLa cells expressing KLF6 under doxycycline control. Data are presented as
media ± SEM. Fisher Test was applied to detect significant difference, p < 0.05. Asterisk (∗), “a” indicate means significantly different.
and invade. KLFs family members have been associated to
carcinogenesis, either counteracting or cooperating with tumor
development (Tetreault et al., 2013). KLF6 function in the
regulation of tumor growth has been validated through several
approaches. KLF6 expression attenuates the tumorigenicity
of glioblastoma multiforme cells both in vitro and in vivo
and is able to inhibit cellular transformation induced by a
variety of oncogenes (Kimmelman et al., 2004). Also, the
upregulation of KLF6 significantly reduces cell proliferation
in prostate cancer (Narla et al., 2001; Narla et al., 2005;
Narla et al., 2007) and in non-small cell lung cancer in
a similar way as p53 does (Ito et al., 2004). Furthermore,
previous results from our laboratory showed that KLF6 down-
regulation predisposes to spontaneous cellular transformation
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FIGURE 4 | Krüppel-like factor 6 silencing interferes with oncogene-induced cellular senescence. (A) Left: Representative micrograph of murine NIH3T3 fibroblasts
stably transduced to express a constitutively active form of H-Ras (H-RasG12V) and either scramble (ras/scr) or KLF6-specific shRNA (ras/shKLF6), cultured during
6 days and processed to detect SA-β-Gal staining (cytoplasmic blue stain). Nuclear fluorescent dye Hoechst was applied to denote cell nuclei (gray stain). Images
were captured X400 magnification. Right: Cellular senescence index expressed as the percentage of SA-β-Gal positive cells. (B) Immunoblotting for KLF6, p53 and
γ-H2AX from murine NIH3T3 fibroblasts expressing H-RasG12V and scramble or shKLF6. Anti-α-tubulin was used as loading control. Images are representative of
three independent experiments. (C) Upper: Representative micrograph of DNA damage response biomarkers: p53, γ-H2AX and phospho ATM by fluorescence
immunodetection on murine NIH3T3 fibroblasts expressing H-RasG12V and scramble or shKLF6. Lower: Fluorescence intensity of each antibody fluorochrome
emission was evaluated in five random chosen fields and normalized by total DNA content area. Data are presented as media ± SEM. Fisher Test was applied to
detect significant difference, p < 0.05.
and increases the tumorigenic potential of NIH3T3 cells,
associated with a reduced expression of p21Waf/Cip1 (Trucco
et al., 2014). Additionally, KLF6 interferes with the oncogenic
signaling and transformation triggered by activated H-Ras
(Trucco et al., 2014).
The precise underlying mechanism by which KLF6 exerts its
tumor suppressor role involves a variety of complex pathways. It
have been described the transactivation of p21Waf/Cip1 in a p53-
independent manner, reduction of cyclin D1/cdk4 complexes
through interaction with cyclin D1, inhibition of c-Jun proto-
oncoprotein activities, decreased VEGF expression and apoptosis
induction (Benzeno et al., 2004; Slavin et al., 2004; Racca et al.,
2016). However, the potential association of KLF6 with cellular
senescence has not been thoroughly defined so far. To date,
some reports have described that KLF6 overexpression results in
the upregulation of differentiation markers associated to a cell
proliferation inhibition and cellular senescence in liposarcoma
(Keung et al., 2015) and glioblastoma (Masilamani et al., 2017).
The induction of senescence involves multiple signals and
genes depending on the cell context, indicating the intricate
nature of this phenotype (Campisi and d’Adda di Fagagna,
2007; Courtois-Cox et al., 2008; d’Adda di Fagagna, 2008).
Frequently, cells with high levels of DNA damage can trigger
cellular senescence and steadily lose their ability to undergo cell
proliferation (Campisi, 2013). Beyond the typical DNA damage,
oncogene activation or DNA replication stress, like the one
elicited by oncogenic mutated Ras (Serrano et al., 1997), is likely
to result in reactive oxygen species or in DNA hyper-replication,
leading to an activation of the DNA damage response, p53
activation and consequently, converging in senescence induction
(Di Micco et al., 2006; Halazonetis et al., 2008; Pospelova
et al., 2009). This response might prevent genomic instability
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accumulation, thus suggesting that senescence acts as a barrier to
cellular transformation. Elucidating the molecular mechanisms
which overrule the cellular responses elicited by genotoxic stimuli
or aberrant proliferation is still a challenge in the tumor growth
field. Herein, we expose the association of KLF6 up-regulation in
two different cellular senescence scenarios. We also observed that
KLF6 silencing bypassed either oxidative or oncogene-induced
senescence. Moreover, KLF6 expression per se was capable to
trigger cellular senescence in both normal and tumoral contexts.
Together, these results provide insights into the mechanism by
which KLF6 plays a suppressing role of uncontrolled or damaged
cell proliferation.
Since KLF6 signaling pathways are assumed to be very
complex and diverse, the exact mechanism by which
KLF6 participate in cellular senescence will require further
investigation. Nonetheless, we position KLF6 as novel factor
capable to induce cellular senescence and a necessary player
for successful senescence establishment (Figures 3A, 4A). This
new role could be related to its known ability to block cell
cycle progression through the regulation of its specific target
genes (e.g., p21Waf/Cip1, cyclin D1, c-Jun, c-Myc, and p53)
(Andreoli et al., 2010). Although other mechanisms cannot be
excluded, such as the transforming growth factor β (TGFβ)
pathway (Kojima et al., 2000), which is a well-established KLF6
target gene that was already associated to cellular senescence
induction (Frippiat et al., 2001; Senturk et al., 2010), making
plausible for both transcription factors to cooperate in the
senescence process (Kojima et al., 2000; Botella et al., 2009;
Dionyssiou et al., 2013). Also, a biological KLF6 cross-talk
with p53 could be considered since several independent
reports proposed that a significant portion of the biological
actions of KLF6 may result from protein-protein interactions
and the extent on the p53 cellular status (Rubinstein et al.,
2004; Andreoli et al., 2010; Gehrau et al., 2011), pointing
KLF6 as a potential p53 partner that contribute to determine
cell fate decisions.
At the end of our study, based on the results in the NIH3T3
model, we overexpressed wild type KLF6 in HeLa cell line derived
from human cervical carcinoma, but we did not overexpress any
of the splice forms since they are not subject of study in the
present brief report. Furthermore, previous works suggested that
the SV1 variant may not have a leading role in the induction of
cellular senescence in other human tumor models. In this sense,
it has been shown that prolonged expression of KLF6-wt, but
not KLF6-sv1, induced a senescent-like phenotype in two cell
lines derived from glioblastoma: LN229 (glioblastoma cell line)
and BTSC23 (Masilamani et al., 2017). Moreover, it was reported
that KLF6 acts as a tumor suppressor in liposarcoma inhibiting
cellular proliferation and invasion, and drive senescence and
differentiation through the regulation of master regulators of
adipogenesis (Keung et al., 2015).
Krüppel-like factor 6 is also considered a stress response
factor as its expression is exhaustively regulated by several
cell-damaging stimuli (Botella et al., 2002; Warke et al.,
2003; Kiang et al., 2004; Slavin et al., 2004; Tahara et al.,
2009; Gehrau et al., 2011). In the present study, both
oncogenic and oxidative stress stimuli were accompanied by
the upregulation of KLF6, similarly to prior reports (Gehrau
et al., 2011; Urtasun et al., 2012; Trucco et al., 2014). Surprisingly,
KLF6 silencing per se showed DNA damage accumulation,
increased p53 expression and also displayed signs of genomic
instability (Figures 3B,C and Supplementary Figures 2I,J),
which could contribute to explain the bias for spontaneous
cellular transformation previously described for this phenotype
(Trucco et al., 2014). KLF6 down-regulation also led to a
rise in the basal index of cellular senescence and, despite
harboring a relatively high level of p53 that could operate to
avoid DNA damage, KLF6-silenced cells still exhibit genetic
instability features (Supplementary Figures 2I,J). This indicates
that KLF6 activity could safeguard DNA stability, as reported
for KLF4 (Hagos et al., 2009). Thus, these findings put
forward a potential role for KLF6 in cellular housekeeping
programs that pursue the control of normal proliferation and
genome maintenance.
Cellular stress and damaging stimuli can lead to senescence
or apoptosis and even both phenotypes simultaneously (Chen
et al., 2000). Recently, relevant molecular mechanistic insights
have appeared with the aim of understanding the relationship
between both cell fates (Childs et al., 2014). In this study,
we observed that senescence outcome yielded priority in both
oxidative and oncogene stress stimuli models. However, KLF6
silencing enhanced the DNA damage and genomic instability
signals gathered after stress exposure, which in turns was coupled
by an increased apoptotic rate whereas cells failed to achieve
senescence status. Seemingly, KLF6 down-regulation could favor
DNA damage accumulation and predispose to cell death.
Several mechanisms could converge to determine cell fate
between senescence and apoptosis after genotoxic stress, as
the extent and duration of DNA damage (Stein et al., 1999;
Rodriguez and Meuth, 2006). On its regard, KLF6 expression
seems to be regulated by the amount of DNA damage since
previous reports denoted that low doses of DNA-damaging agent
did not affect KLF6 expression while high doses compatible
with apoptosis induction, ended in a down-regulation of its
levels (Banck et al., 2006; D’Astolfo et al., 2008). In fact,
in line with the results presented here, KLF6 knockdown in
hepatocarcinoma cells render cells more susceptible to DNA-
damage induced apoptosis, indicating that endogenous KLF6
may act at some level blocking apoptosis entry (Sirach et al.,
2007; D’Astolfo et al., 2008). Moreover, KLF6 expression in
Ras-transformed and tumoral HeLa cells shows to confer
a cell death resistance upon treatment with DNA-damaging
agents (D’Astolfo et al., 2008; Trucco et al., 2014). Thus, in a
context of genotoxic stress, KLF6 may favor apoptosis blockage
and, direct or indirectly, participate in senescence induction.
This observation raises the possibility that KLF6 could engage
senescence and apoptosis pathways in certain processes or
stress responses.
In conclusion, based on the results presented herein, we
suggest that KLF6 may be in part necessary in the induction
of the cellular senescence program in response to cell damage
stimuli such as oncogenic and oxidative stress. Our data provide
insights into the potential mechanism by which KLF6 may play
a role in suppressing DNA damage accumulation as well as
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in oxidative stress responses, and implicate KLF6 in genome
maintenance and protection against aberrant cell proliferation.
These findings helps to strengthen the understanding of KLF6
function in cellular growth contexts rendering possible for its
tumor suppressor activity to be mediated by cellular senescence,
representing an alarm sign in response to certain stimuli that lead
to an exacerbated proliferation or cell transformation.
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